Search Results for "Schizophrenia Studies"
Matching Channels
Schizophrenia is a common serious long-term mental health condition that affects 5 in 1000 in the UK. It causes a range of different psychological symptoms; hallucinations, delusions, muddled...
Schizophrenia and Related Disorders
Matching News
New Study Suggests Schizophrenia May Be VA Disorder Of Neurodevelopment And Accelerated Aging
Many lines of evidence indicate that schizophrenia is a disorder of neurodevelopment. For example, genes implicated in the heritable risk for schizophrenia are also implicated in the development of ne...
Genetic risk for schizophrenia is connected to reduced IQ
(Elsevier) The relationship between the heritable risk for schizophrenia and low intelligence has not been clear. Schizophrenia is commonly associated with cognitive impairments that may cause functio...
Reading Impairments In Schizophrenia Revealed By Eye Movements
A study of eye movements in schizophrenia patients provides new evidence of impaired reading fluency in individuals with the mental illness. The findings, by researchers at McGill University in Montre...
Study provides new evidence that genetic risk for schizophrenia associated with lower IQ
The relationship between the heritable risk for schizophrenia and low intelligence has not been clear. Schizophrenia is commonly associated with cognitive impairments that may cause functional disabil...
The Dual Role Of Testosterone In Schizophrenia
Researchers from Neuroscience Research Australia (NeuRA) have presented new results about the role of testosterone in schizophrenia at the International Congress on Schizophrenia Research being held i...
Rising placebo response seen in schizophrenia trials
NEW YORK (Reuters Health) - Studies of schizophrenia drugs are increasingly finding lesser effects because more patients are responding to drug-free placebos used for comparison, according to a new Un...
Lilly Stops Phase III Development of Schizophrenia Treatment
Eli Lilly and Company announced today the decision to stop ongoing clinical studies investigating pomaglumetad methionil, also known as mGlu2/3, for the treatment of patients suffering from schizophre...
Lilly ends studies of new schizophrenia drug
Eli Lilly and Co. said Wednesday it is ending studies of an experimental schizophrenia drug based on negative clinical trial results.Lilly said an analysis showed a late-stage study of pomaglumetad m...
Matching PubMed Articles
DNA methylation in schizophrenia: progress and challenges of epigenetic studies.
ABSTRACT: Schizophrenia is a severe psychiatric disease affecting about 1% of the world's population, with significant effects on patients and society. Genetic studies have identified several candidat...
Cannabis abuse and brain morphology in schizophrenia: a review of the available evidence.
Substance abuse is the most prevalent comorbid psychiatric condition associated with schizophrenia, and cannabis is the illicit drug most often abused. Apart from worsening the course of schizophrenia...
Resting EEG deficits in accused murderers with schizophrenia.
Empirical evidence continues to suggest a biologically distinct violent subtype of schizophrenia. The present study examined whether murderers with schizophrenia would demonstrate resting EEG deficits...
Catatonic Schizophrenia: A Cohort Prospective Study.
Background: In the 20th century, catatonia was usually deemed a subtype of schizophrenia. Recently, the nature and classification of catatonia are being reconsidered. This study is the first to descri...
Increased Levels of Kynurenine and Kynurenic Acid in the CSF of Patients With Schizophrenia.
Background: The kynurenic acid (KYNA) hypothesis for schizophrenia is partly based on studies showing increased brain levels of KYNA in patients. KYNA is an endogenous metabolite of tryptophan (TRP) p...
